RECRUITINGOBSERVATIONAL
The Clinical Significance of CT-based Biomarkers in the Classification and Prognosis of Bronchiectasis
About This Trial
As the third major chronic airway disease in China, bronchiectasis has a wide range of patients. However, the involved sites, morphological features and airway obstruction of bronchiectasis are varied, and clinical heterogeneity is high, making prognosis and severity difficult to evaluate. CT plays an important role in the diagnosis and classification of ramadasis. Based on this, we analyzed the CT findings of patients with bronchiectasis and followed up patients with bronchiectasis to understand their disease progression and prognosis, so as to further analyze the role of CT biomarkers in the type and prognosis of bronchiectasis diseases.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age 18 years and above;
- Can cooperate with CT scan;
- Bronchiectasis confirmed by high-resolution computed tomography of the lungs;
- Can provide written willing to sign a consent form
Who Should NOT Join This Trial:
- Pulmonary surgery;
- Patients with lung cancer, asthma and other respiratory diseases;
- Tractive bronchiectasis caused by pulmonary fibrosis;
- Patients with malignant tumors or serious dysfunction of the heart, brain, kidney and other important systems can not cooperate with the completion of this study;
- Lack of important clinical information.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age 18 years and above;
* Can cooperate with CT scan;
* Bronchiectasis confirmed by high-resolution computed tomography of the lungs;
* Can provide written informed consent
Exclusion Criteria:
* Pulmonary surgery;
* Patients with lung cancer, asthma and other respiratory diseases;
* Tractive bronchiectasis caused by pulmonary fibrosis;
* Patients with malignant tumors or serious dysfunction of the heart, brain, kidney and other important systems can not cooperate with the completion of this study;
* Lack of important clinical information.
Locations (1)
Wuhan Union Hospital
Wuhan, Hubei, China